Using Economic Evaluation in Policy Decision-Making in Asian Countries: Mission Impossible or Mission Probable?
Open accessAbstract
Objectives and methods This article provides an extensive review of literature and an in-depth analysis aimed at introducing potential applications of economic evaluation and at addressing the barriers that could prohibit the use or diminish the usefulness of economic evaluation in Asian settings. It also proposes the probable solutions to overcome these barriers.Results Potential uses of economic evaluation include the development of public reimbursement lists, price negotiation, the development of clinical practice guidelines, and communicating with prescribers. Two types of barriers to using economic evaluation, namely barriers relating to the production of economic evaluation data and decision context-related barriers, are identified. For the first sort of barrier, the development of the national guidelines, the development of economic evaluation database, planning and use of economic evaluation in a systematic manner, and prioritization of topics for assessment are recommended. Furthermore, educating potential users and the public, making the economic evaluation process transparent and participatory, and incorporating other health preferences into the decision-making framework have been promoted to conquer decision context-related barriers.Conclusions It seems practically impossible to adopt other countries' approaches using economic evaluation for priority setting because of several constraints specifically related to the context of each setting. Nevertheless, given a better understanding of its resistance, and proper policies and strategies to overcome the barriers applied, it is more than probable that a method with system/mechanisms specifically designed to fit particular settings will be used.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Economic evaluations are one of many important factors in decision-making about EBP use.
“Research from varied global contexts consistently shows that economic evaluations are one of many important factors in decision-making about EBP use [16–18].”
From Translating economic evaluations into financing strategies for implementing evidence-based practices (2021) · cites this paper as [18]
Cites
National Institute for Clinical Excellence and its value judgments
Rawlins, M. D., & Culyer, A. J. (2004) · BMJ · doi:10.1136/bmj.329.7459.224 · Cited by 771 · see citing works
Pricing life: why it's time for health care rationing
(2000) · Choice Reviews Online · doi:10.5860/choice.37-5709 · Cited by 211 · see citing works
The influence of economic evaluation studies on decision making.
Hoffmann, C. (2000) · Health Policy · doi:10.1016/s0168-8510(00)00076-2 · Cited by 202 · see citing works
The role of economic evaluation in the pricing and reimbursement of medicines
Drummond, M., Jönsson, B., & Rutten, F. (1997) · Health Policy · doi:10.1016/s0168-8510(97)00901-9 · Cited by 129 · see citing works
Pricing Life: Why It's Time for Health Care RationingPreprint
Ubel, P. A. (1999) · RePEc: Research Papers in Economics · Cited by 119 · see citing works
Iglesias, C. P., Drummond, M., Rovira, J., et al. (2005) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462305050014 · Cited by 103 · see citing works
Using Cost-Effectiveness Analysis to Improve Health Care: Opportunities and Barriers
Moynihan, R. N. (2005) · BMJ · doi:10.1136/bmj.330.7503.1336-a · Cited by 82 · see citing works
Using Cost-Effectiveness Analysis to Improve Health Care
Neumann, P. J. (2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195171860.001.0001 · Cited by 74 · see citing works
Yang, B., Bae, E.-Y., & Kim, J. (2008) · Health Affairs · doi:10.1377/hlthaff.27.1.179 · Cited by 72 · see citing works
Limits to rationality: economics, economists and priority setting
Robinson, R. (1999) · Health Policy · doi:10.1016/s0168-8510(99)00040-8 · Cited by 67 · see citing works
A Systematic Review of Economic Evaluation Literature in Thailand
Teerawattananon, Y., Russell, S., & Mugford, M. (2007) · PharmacoEconomics · doi:10.2165/00019053-200725060-00003 · Cited by 62 · see citing works
Self-citationHealth-Care Systems and Pharmacoeconomic Research in Asia-Pacific Region
Tarn, Y.-H., Hu, S., Kamae, I., et al. (2008) · Value in Health · doi:10.1111/j.1524-4733.2008.00378.x · Cited by 61 · see citing works
Harris, A., Buxton, M. J., OʼBrien, B. J., & Drummond, F. R. A. M. (2001) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.1.1.7 · Cited by 58 · see citing works
Tantivess, S., Teerawattananon, Y., & MILLS, A. J. (2009) · PharmacoEconomics · doi:10.2165/11314710-000000000-00000 · Cited by 56 · see citing works
Self-citationCairns, J. (2005) · Health Policy · doi:10.1016/j.healthpol.2005.05.006 · Cited by 54 · see citing works
Drummond, M. (1994) · Social Science & Medicine · doi:10.1016/0277-9536(94)90059-0 · Cited by 52 · see citing works
Pharmacoeconomics and Clinical Practice Guidelines
Anell, A., & Svarvar, P. (2000) · PharmacoEconomics · doi:10.2165/00019053-200017020-00006 · Cited by 46 · see citing works
Teerawattananon, Y., & Russell, S. (2008) · Value in Health · doi:10.1111/j.1524-4733.2008.00367.x · Cited by 45 · see citing works
Self-citationMobley, L. R., Hoerger, T. J., Wittenborn, J. S., et al. (2006) · Medical Decision Making · doi:10.1177/0272989x06286478 · Cited by 43 · see citing works
Ferner, R. E., & McDowell, S. E. (2006) · BMJ · doi:10.1136/bmj.332.7552.1268 · Cited by 43 · see citing works
Lee, K.-S., Brouwer, W. B. F., Lee, S., et al. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523070-00005 · Cited by 33 · see citing works
Teerawattananon, Y. (2004) · Health Policy and Planning · doi:10.1093/heapol/czh043 · Cited by 30 · see citing works
Self-citationSetting priorities for the evaluation of health interventions: when theory does not meet practice
Sassi, F. (2003) · Health Policy · doi:10.1016/s0168-8510(02)00061-1 · Cited by 29 · see citing works
Ikegami, N., Drummond, M., Fukuhara, S., et al. (2002) · PharmacoEconomics · doi:10.2165/00019053-200220002-00001 · Cited by 27 · see citing works
The Diffusion of Health Economics Knowledge in Europe
de Pouvourville, G., Ulmann, P., Nixon, J., et al. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523020-00003 · Cited by 26 · see citing works
Singer, M. E. (2008) · PharmacoEconomics · doi:10.2165/00019053-200826050-00001 · Cited by 24 · see citing works
Teerawattananon, Y., & Russell, S. (2008) · BMC Health Services Research · doi:10.1186/1472-6963-8-197 · Cited by 23 · see citing works
Self-citationUsing cost-effectiveness analyses to inform policy: the case of antiretroviral therapy in Thailand.
Tantivess, S., & Walt, G. (2006) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-4-21 · Cited by 16 · see citing works
Self-citationEthical Foundations of Health Care Responsibilities in Decision Making
Singleton, J., & Goodinson-Mclaren, S. (1995) · DigitalGeorgetown (Georgetown University Library) · Cited by 13 · see citing works
Wonder, M. J., Neville, A. M., & Parsons, R. W. (2006) · Value in Health · doi:10.1111/j.1524-4733.2006.00104.x · Cited by 10 · see citing works
Kapol, N., Maitreemit, P., Chalongsuk, R., et al. (2008) · PubMed · Cited by 9 · see citing works
Ethical foundations of health care. Responsibilities in decision making
Dines, A. M. (1996) · Journal of Medical Ethics · doi:10.1136/jme.22.1.58 · Cited by 6 · see citing works
Making sensible rationing: the use of economic evidence and the need for methodological standards.
Tangcharoensathien, V., & Kamolratanakul, P. (2008) · PubMed · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Translating economic evaluations into financing strategies for implementing evidence-based practices
Dopp, A. R., Kerns, S. E. U., Panattoni, L., Ringel, J. S., Eisenberg, D., Powell, B. J., Low, R., & Raghavan, R. (2021) · Implementation Science · doi:10.1186/s13012-021-01137-9 · Cited by 52 · see citing works
- Authors
- Yothasamut, J., Tantivess, S., & Teerawattananon, Y.
- Affiliations
- Ministry of Public Health (TH)
- Venue
- Value in Health
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 12
- Pages
- S26-S30
- ISSN
- 1098-3015 (ISSN-L)
- OpenAlex
- W2126162559
- Cited by
- 61
- References
- 33
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 1 · 2023: 1 · 2021: 4 · 2020: 8 · 2019: 2 · 2018: 3 · 2017: 4 · 2016: 5 · 2015: 7 · 2014: 4 · 2013: 6 · 2012: 9
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Value in Health (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Thai Health Promotion Foundation
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Social Sciences › Decision Sciences › Management Science and Operations Research › Evaluation and Performance Assessment
- Keywords
- economic evaluation, health policy decision-making, priority setting, price negotiation, health preferences, Asia
- MeSH terms
- Asia, Cost-Benefit Analysis, Developing Countries, Health Policy, Humans, Policy Making, Quality-Adjusted Life Years
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
